Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19: A Randomized Trial

BACKGROUND: No effective oral therapy exists for early coronavirus disease 2019 (COVID-19). OBJECTIVE: To investigate whether hydroxychloroquine could reduce COVID-19 severity in adult outpatients. DESIGN: Randomized, double-blind, placebo-controlled trial conducted from 22 March through 20 May 2020...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Ann Intern Med
Auteurs principaux: Skipper, Caleb P., Pastick, Katelyn A., Engen, Nicole W., Bangdiwala, Ananta S., Abassi, Mahsa, Lofgren, Sarah M., Williams, Darlisha A., Okafor, Elizabeth C., Pullen, Matthew F., Nicol, Melanie R., Nascene, Alanna A., Hullsiek, Kathy H., Cheng, Matthew P., Luke, Darlette, Lother, Sylvain A., MacKenzie, Lauren J., Drobot, Glen, Kelly, Lauren E., Schwartz, Ilan S., Zarychanski, Ryan, McDonald, Emily G., Lee, Todd C., Rajasingham, Radha, Boulware, David R.
Format: Artigo
Langue:Inglês
Publié: American College of Physicians 2020
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7384270/
https://ncbi.nlm.nih.gov/pubmed/32673060
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/M20-4207
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires